9 completed, 2 unknown, 1 recruiting. 12 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 9, Unknown 2, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Parenteral Nutrition: new trials by email Literature Review of Parenteral Nutrition trials Research Report on Parenteral Nutrition
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition NTCB02-1, NTCB-C - Parenteral Nutrition | Phase 3 | Recruiting | Yuhan Corporation | 60 | 2024-12-04 | 2025-01-07 |
| Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition NTCB01-1, NTCB-P - Parenteral Nutrition | Phase 3 | Completed | Yuhan Corporation | 60 | 2024-11-14 | 2025-05-15 |
| A Phase Ⅲ Study of HR19006 Injection in Postsurgical Parenteral Nutrition HR19006, All-in-one parenteral nutrition - Parenteral Nutrition | Phase 3 | Unknown | Fujian Shengdi Pharmaceutical Co., Ltd. | 240 | 2023-04-28 | 2023-10-10 |
| Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301 IN-C006 Peri inj., RPN301 - Parenteral Nutrition | Phase 3 | Completed | HK inno.N Corporation | 59 | 2022-08-09 | 2023-09-28 |
| Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301 IN-C006 inj., RCN301 - Parenteral Nutrition | Phase 3 | Completed | HK inno.N Corporation | 60 | 2022-05-04 | 2023-09-28 |
| Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral Nutrition SmofKabiven emulsion for infusion, Hospital compounded "All in one" emulsion - Parenteral Nutrition, Surgery | Phase 3 | Completed | Fresenius Kabi | 273 | 2019-01-03 | 2021-08-02 |
| Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS Perioperative peripheral parenteral nutrition - Colon Cancer, Parenteral Nutrition | Phase 3 | Unknown | Antonio Arroyo Sebastian | 200 | 2016-10-01 | 2018-07-31 |
| Efficacy and Safety of a Fish Oil Containing Lipid Emulsion fish oil containing lipid emulsion, MCT/LCT containing lipid emulsion - Parenteral Nutrition | Phase 3 | Completed | B. Braun Melsungen AG | 240 | 2010-04-01 | 2012-01-10 |
| Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN ClinOleic 20% Intravenous Emulsion, Intralipid, 20% Intravenous Emulsion - Parenteral Nutrition | Phase 2 / Phase 3 | Completed | Emory University | 100 | 2008-11-01 | 2018-10-17 |
| Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition SMOF lipid and Intralipid - Parenteral Nutrition | Phase 3 | Completed | Fresenius Kabi | 75 | 2007-10-01 | 2010-08-27 |
| The AOT (Acridine Orange and Taurolidine) Trial taurolidine - Parenteral Nutrition, Infection | Phase 3 | Completed | Radboud University Medical Center | 60 | 2006-06-01 | 2009-02-11 |
| The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients Omega-3 fish oil emulsion (Omegaven ), long-chain triglyceride - Carcinoma Surgery, Parenteral Nutrition | Phase 3 | Completed | Sino-Swed Pharmaceutical Corporation | 206 | 2002-06-01 | 2008-05-14 |
Hyperphagia (12) · Colonic Neoplasms (1) · Cross Infection (1) · Infections (1) · Insulin Resistance (1) · Sepsis (1)
Pathological Conditions, Signs and Symptoms (12) · Signs and Symptoms (12) · Signs and Symptoms, Digestive (12) · Pathologic Processes (2) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Disease Attributes (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Iatrogenic Disease (1) · Infections (1)
soybean oil, phospholipid emulsion (3) · ClinOleic (1) · Fat Emulsions, Intravenous (1) · fish oil triglycerides (1) · taurolidine (1)
Fresenius Kabi (2) · HK inno.N Corporation (2) · Yuhan Corporation (2) · Antonio Arroyo Sebastian (1) · B. Braun Melsungen AG (1) · Emory University (1) · Fujian Shengdi Pharmaceutical Co., Ltd. (1) · Radboud University Medical Center (1) · Sino-Swed Pharmaceutical Corporation (1)
China (4) · South Korea (4) · Netherlands (2) · Australia (1) · Denmark (1) · France (1) · Israel (1) · Poland (1) · Spain (1) · United Kingdom (1) · United States (1)
Antonio Arroyo, MD (1) · Geert Wanten, MD, PhD (1) · Guillermo Umpierrez, MD (1) · Jon Shaffer, MD (1) · Ning Li, Prof. MD. PhD. (1) · Zhang Zhongtao, MD (1) · Zhu-ming Jiang, FACS (1)